Correlationship Between HCV-1b Gene Mutations Genotype and Therapeutic Effects of Interferon/ribavirin in Patients with Chronic HCV-1b Infection

MAO Yuan,MIAO Shen-wei,WANG Wei,QIU Jie,SHEN Chuan-lai,SHEN Ling,HU Zhao-hui,XIE Wei

DOI: https://doi.org/10.3877/cma.j.issn.1674-1358.2013.03.011

2013-01-01

Abstract:Objective To investigate whether mutations in ISDR, PKR-BD, NS5A-V3 and E2-PePHD regions of HCV-1b genotype inlfuence the efifcacy of interferon/ribavirin in patients with chronic HCV-1b infection. Methods The pretreatment serum samples from patients, who had chronic infection of HCV-1b and completed the course of interferon/ribavirin combination therapy as well as a 6-months follow-up, were collected, respectively. The pretreatment mutations in nucleic acid sequence of ISDR, PKR-BD, NS5A-V3 and E2-PePHD regions of HCV-1b were identified by RT-PCR products sequencing followed by comparison with the prototype sequence (HCV-J). Correlationship with the clinical efifcacy of interferon/ribavirin combination therapy was then analyzed, retrospectively. Results Total of 169 patients with chronic HCV infection were enrolled in the retrospective study. Among these patients, 124 (74.4%) were infected by HCV-1b genotype. The statistical analysis indicated a significant correlationship between the mutations in ISDR and sustained virological response (SVR) to interferon/ribavirin treatment (P<0.05). The SVR rates of patients infected with wild-type, intermediate-type and mutant-type ISDR strains were 30%, 55%and 85.7%, respectively. However, there was no signiifcant association among the mutations in PKR-BD, NS5A-V3 and E2-PePHD regions and SVR (P>0.05). Conclusions The pretreatment mutations in ISDR of NS5A gene have important predictive value for therapeutic effects of interferon/ribavirin to patients with HCV-1b infection.